(Q28239975)

English

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

scientific article (publication date: April 2005)

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Christian W Hamm

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

12

object named as

Gregg W Stone

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

11

object named as

Philip Urban

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Witold Rużyłło

10

object named as

Witold Ruzyllo

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Sigmund Silber

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Per Albertsson

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Francisco F Avilés

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Paolo G Camici

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Antonio Colombo

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Erik Jørgensen

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jean Marco

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jan-Erik Nordrehaug

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

0 references

publication date

15 March 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

European Heart Journal

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

804-847

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Percutaneous coronary interventions in Europe 1992-2001.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to M

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Drug therapy or coronary angioplasty for the treatment of coronary artery disease: new insights

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Primary stenting of occluded native coronary arteries: final results of the Primary Stenting of Occluded Native Coronary Arteries (PRISON) study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) in

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

One-year clinical outcomes of protected and unprotected left main coronary artery stenting.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Rapamycin-eluting stents for the treatment of unprotected left main coronary disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Evidence for use of coronary stents. A hierarchical bayesian meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: The Venestent Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A comparison of coronary artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery: five year clinical follow up.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Predictors of troponin elevation after percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Troponin I elevation and cardiac events after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Abciximab-facilitated percutaneous coronary intervention and long-term survival—a prospective single-center registry

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

"Ischemia-guided" versus "early invasive" strategies in the management of acute coronary syndrome/non-ST-segment elevation myocardial infarction: the interventionalist's perspective

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Correlation of TIMI risk score with angiographic severity and extent of coronary artery disease in patients with non-ST-elevation acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Evidence-based risk stratification to target therapies in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Non-ST-elevation acute coronary syndrome in the elderly: treatment strategies and 30-day outcome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Natriuretic peptides in unstable coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Volume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York state

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

The association between hospital volume and survival after acute myocardial infarction in elderly patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Thera

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Hospital percutaneous coronary intervention volume and patient mortality, 1998 to 2000: does the evidence support current procedure volume minimums?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Transluminal dilatation of coronary-artery stenosis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO II-B) Angioplasty Substudy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Fibrinolytic therapy: is it a treatment of the past?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Impact of Prehospital Thrombolysis for Acute Myocardial Infarction on 1-Year Outcome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

In-hospital mortality associated with the use of intra-aortic balloon counterpulsation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leit

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Lyse now, stent later: the grace of GRACIA.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Use of intracoronary adenosine for the management of slow-no-reflow phenomenon during percutaneous interventions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Aspirin resistance: more than just a laboratory curiosity

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Clinical implications of percutaneous coronary intervention-clopidogrel in unstable angina to prevent recurrent events (PCI-CURE) study: a US perspective

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice G

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

The role of low-molecular-weight heparin in the management of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Clinical impact of abciximab on long‐term outcome after complex coronary angioplasty

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Upstream use of tirofiban in patients admitted for an acute coronary syndrome in hospitals with or without facilities for invasive management. PRISM-PLUS Investigators.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Unstable angina and non-ST-elevation myocardial infarction: initial antithrombotic therapy and early invasive strategy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Optimal treatment of acute coronary syndromes--an evolving strategy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

"Routine invasive" versus "selective invasive" approaches to non-ST-segment elevation acute coronary syndromes management in the post-stent/platelet inhibition era.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Antiplatelet therapy for ischemic heart disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: a meta-analysis of randomized, controlled trials.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Five-year outcome of patients with acute myocardial infarction enrolled in a randomised trial assessing the value of abciximab during coronary artery stenting.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A preferred reperfusion strategy for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Direct thrombin inhibitors for non-ST–segment elevation acute coronary syndromes: what, when, and where?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Effect of bivalirudin on length of stay in the recovery area after percutaneous coronary intervention compared with heparin alone, heparin + abciximab, or heparin + eptifibatide

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

The evolving role of direct thrombin inhibitors in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A multicentre European registry of intraluminal coronary beta brachytherapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

New frontiers in interventional cardiology: intravascular radiation to prevent restenosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomized trial of Rotational Atherectomy Versus Balloon Angioplasty for Diffuse In-stent Restenosis (ROSTER).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Comparison of directional coronary atherectomy and stenting versus stenting alone for the treatment of de novo and restenotic coronary artery narrowing.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Recognition of the importance of embolization in atherosclerotic vascular disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

The Dutch experience in percutaneous transluminal angioplasty of narrowed saphenous veins used for aortocoronary arterial bypass

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

GuardWire emboli protection device is associated with improved myocardial perfusion grade in saphenous vein graft intervention.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Applicability of distal protection for aortocoronary vein graft interventions in clinical practice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Preliminary experiences using X-sizer catheter for mechanical thrombectomy of thrombus-containing lesions during acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Initial experience with the Endicor X-sizer thrombectomy device in patients with ST segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Distal protection with a filter device during coronary stenting in patients with stable and unstable angina.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Incidence, correlates, management, and clinical outcome of coronary perforation: analysis of 16,298 procedures.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate: a multicenter, randomized study comparing two strategies--with and without intravascular ultrasound guidance. RESIST Study Group. REStenosis after Ivus guide

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Routine intravascular ultrasound scanning guidance of coronary stenting is not associated with improved clinical outcomes.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Comparison between visual assessment and quantitative angiography versus fractional flow reserve for native coronary narrowings of moderate severity

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Is it time to measure fractional flow reserve in all patients?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Plaque sealing by coronary angioplasty

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Who wants his plaque sealed?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameter

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Study of antirestenosis with the BiodivYsio dexamethasone‐eluting stent (STRIDE): A first‐in‐human multicenter pilot trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Evaluation of a high-dose dexamethasone-eluting stent.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Which parameter should be chosen as primary endpoint for randomized drug-eluting stent studies?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Paclitaxel-eluting stents: are they all equal? An analysis of six randomized controlled trials in de novo lesions of 3,319 patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Use of sirolimus-eluting coronary stents in routine clinical practice

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Stent thrombosis after successful sirolimus-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Major noncardiac surgery following coronary stenting: when is it safe to operate?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Drug-eluting stent task force: final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Elective sirolimus-eluting stent implantation for left main coronary artery disease: six-month angiographic follow-up and 1-year clinical outcome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

International differences in in-hospital revascularization and outcomes following acute myocardial infarction A multilevel analysis of patients in ASSENT-2

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Abciximab improves 6-month clinical outcome after rescue coronary angioplasty

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Intracoronary Thrombectomy With the X-Sizer Catheter System Improves Epicardial Flow and Accelerates ST-Segment Resolution in Patients With Acute Coronary Syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Minimal heparinization in coronary angioplasty—how much heparin is really warranted?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following cita

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI138

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHI138

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

release_euszlndn5jdozht4abq25hyjrq

1 reference

https://api.fatcat.wiki/v0/release/euszlndn5jdozht4abq25hyjrq

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15769784%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28239975&oldid=1842707306"